|
1. Pervez N, Khan SA, Hussain SR. Thrombocytopenia in cases of Helicobacter pylori infection. Pak Armed Forces Med J 2021;71:129-32. 2. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998;352:878. [ DOI:10.1016/S0140-6736(05)60004-9] 3. Byrne MF, Kerrigan SW, Corcoran PA, Atherton JC, Murray FE, Fitzgerald DJ, et al. Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. Gastroenterology. 2003;124:1846-54. [ DOI:10.1016/S0016-5085(03)00397-4] 4. Ihtesham A, Maqbool S, Nadeem M, Bilawal Abbas Janjua M, Sundus O, Bakht Naqqash A, et al. Helicobacter pylori induced Immune Thrombocytopenic Purpura and perspective role of Helicobacter pylori eradication therapy for treating Immune Thrombocytopenic Purpura. AIMS Microbiol 2021;7:284-303. [ DOI:10.3934/microbiol.2021018] 5. Franchini M, Cruciani M, Mengoli C, Pizzolo G, Veneri D. Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: a systematic review and meta-analysis. J Antimicrob Chemother 2007;60:237-46. [ DOI:10.1093/jac/dkm195] 6. Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood 2009;113:6511-21. [ DOI:10.1182/blood-2009-01-129155] 7. Lubberts B, D'Hooghe P, Bengtsson H, DiGiovanni CW, Calder J, Ekstrand J. Epidemiology and return to play following isolated syndesmotic injuries of the ankle: a prospective cohort study of 3677 male professional footballers in the UEFA Elite Club Injury Study. Br J Sports Med 2017;53:959-64. [ DOI:10.1136/bjsports-2017-097710] 8. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002;346:995-1008. [ DOI:10.1056/NEJMra010501] 9. Zufferey A, Kapur R, Semple JW. Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). J Clin Med 2017;6:16. [ DOI:10.3390/jcm6020016] 10. Kashiwagi H, Kuwana M, Hato T, Takafuta T, Fujimura K, Kurata Y, et al. Reference guide for management of adult immune thrombocytopenia in Japan: 2019 Revision. Int J Hematol 2020;111:329-51. [ DOI:10.1007/s12185-019-02790-z] 11. Audia S, Mahévas M, Samson M, Godeau B, Bonnotte B. Pathogenesis of immune thrombocytopenia. Autoimmun Rev 2017;16:620-32. [ DOI:10.1016/j.autrev.2017.04.012] 12. Aljarad S, Alhamid A, Tarabishi AS, Suliman A, Aljarad Z. The impact of Helicobacter pylori eradication on platelet counts of adult patients with idiopathic thrombocytopenic purpura. BMC Hematol 2018;18:1-8. [ DOI:10.1186/s12878-018-0119-y] 13. Hwang JJ, Lee DH, Yoon H, Shin CM, Park YS, Kim N. The effects of Helicobacter pylori eradication therapy for chronic idiopathic thrombocytopenic purpura. Gut Liver 2016;10:356. [ DOI:10.5009/gnl14483] 14. Brito HSH, Braga JAP, Loggetto SR, Machado RS, Granato CFH, Kawakami E. Helicobacter pylori infection and immune thrombocytopenic purpura in children and adolescents: a randomized controlled trial. Platelets 2015;26:336-41. [ DOI:10.3109/09537104.2014.911836] 15. Hasni SA. Role of Helicobacter pylori infection in autoimmune diseases. Curr Opin Rheumatol 2012;24:429-34. [ DOI:10.1097/BOR.0b013e3283542d0b] 16. Stasi R, Provan D. Helicobacter pylori and chronic ITP. Hematology Am Soc Hematol Educ Program 2008:206-11. [ DOI:10.1182/asheducation-2008.1.206] 17. Frydman GH, Davis N, Beck PL, Fox JG. Helicobacter pylori eradication in patients with immune thrombocytopenic purpura: a review and the role of biogeography. Helicobacter 2015;20:239-51. [ DOI:10.1111/hel.12200] 18. Tag HS, Lee HS, Jung SH. Effects of Helicobacter pylori eradication in patients with immune thrombocytopenic purpura. Korean J Hematol 2010;45:127-32. [ DOI:10.5045/kjh.2010.45.2.127] 19. Kuwana M, Ikeda Y. Helicobacter pylori and immune thrombocytopenic purpura: unsolved questions and controversies. Int J Hematol 2006;84:309-15. [ DOI:10.1532/IJH97.06188] 20. Rostami N, Keshtkar-Jahromi M, Rahnavardi M, Keshtkar-Jahromi M, Esfahani FS. Effect of eradication of Helicobacter pylori on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura: a controlled trial. Am J Hematol 2008;83:376-81. [ DOI:10.1002/ajh.21125] 21. Suzuki T, Matsushima M, Masui A. Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura-a randomized controlled trial. Am J Gastroenterol 2005;100:1265-71. [ DOI:10.1111/j.1572-0241.2005.41641.x] 22. Stasi R, Sarpatwari A, Segal JB. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood 2009;113:1231-40. [ DOI:10.1182/blood-2008-07-167155] 23. Takahashi T, Yujiri T, Shinohara K, Inoue Y, Sato Y, Fujii Y, et al. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura. Br J Haematol 2004;124:91-96. [ DOI:10.1046/j.1365-2141.2003.04735.x] 24. Jarque I, Andreu R, Llopis I. Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura. Br J Haematol 2001;115:1002-1003. [ DOI:10.1046/j.1365-2141.2001.03194.x] 25. Michel M, Cooper N, Jean C, Frissora C, Bussel JB. Does Helicobacter pylori initiate or perpetuate immune thrombocytopenic purpura? Blood 2004;103:890-96. [ DOI:10.1182/blood-2003-03-0900] 26. Emilia G, Longo G, Luppi M. Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Blood 2001;97:812-14. [ DOI:10.1182/blood.V97.3.812] 27. Koseki M, Sheu MJ, Tsai KT, Ho CH, Liu HH, Lin HJ, et al. Eradication therapy may decrease the risk of immune thrombocytopenia after Helicobacter pylori infection: a retrospective cohort study in Taiwan. BMC Gastroenterol 2023;23:36. [ DOI:10.1186/s12876-023-02664-z] 28. Sağlam NÖ, Civan HA. Impact of chronic Helicobacter pylori infection on inflammatory markers and hematological parameters. Eur Rev Med Pharmacol Sci 2023;27:969-79.
|
